Cell Collections

Certain types of cancers and autoimmune diseases can be treated with the help of stem cell therapies,¹ which begin with collecting the optimal cells to support bone marrow recovery and blood cell production. Spectra Optia brings precision to your stem cell collections with multiple protocols and analytical tools to optimize them.

Watch the videos below for more information on the stem cell therapy collection procedures called continuous mononuclear cell collection (CMNC) and mononuclear cell collection (MNC).

Videos - Demo - 5 min

Continuous Mononuclear Cell Collection (CMNC Protocol)

Videos - Demo - 6 min

Mononuclear Collection (MNC Protocol)

Every day, across the globe, demand is increasing for the manufacturing and commercialization of cell and gene therapies. This inspires new ideas for CAR T-cell therapies but also presents real challenges for CGT manufacturers and collection sites to effectively scale. Leveraging our expertise and comprehensive data management solutions, we help our customers improve the quality of their starting material and get more insight into their cell collection process.

Video - On-Demand Webinar - 60 min

Challenges of Cell Collections for Cell Therapy Manufacturing: What Do We Want in the Bag?

Video - Expert Insights - 2 min

5 Things Manufacturers Must Do to Scale Cell Collections

Granulocytes (PMNs) are collected from donors to help control infection after transplants, chemotherapy, and other life-saving treatments.² Spectra Optia continuously monitors and interprets the cell interface and adjusts collection accordingly to target just the desired cells. That, combined with unparalleled training and operator support, helps enable effective and efficient procedures.